Type I IFN immunoprofiling in COVID-19 patients
Type I IFN immunoprofiling in COVID-19 patients
复制标题
DOI：
10.1016/j.jaci.2020.04.029
复制
发表时间：
2020-07-01
影响因子：
14.2
通讯作者：
Belot, Alexandre
中科院分区：
文献类型：
--
作者：
Trouillet-Assant, Sophie;Viel, Sebastien;Belot, Alexandre
资助：quanterix为本研究免费提供试剂盒。pons S, Oriol G, Brengel-Pesce K, Mouton W， Compagnon C是biomacrieux®38名员工。我们感谢两位临床研究助理Gaelle Cavillon和Salima Merazga出色的工作。我们感谢Fabien Subtil对统计分析提出的有益建议。41我们也感谢里昂免疫病理联合会（LIFE）社区富有成果的讨论。42©Elsevier出版。这份手稿是在爱思唯尔用户许可https://www下提供的。爱思唯尔。com/open-access/userlicense/1.0/
Funding-Quanterix provided the kits for this study free of charge. 37 Conflict of interest–Pons S, Oriol G, Brengel-Pesce K, Mouton W, Compagnon C are Biomérieux® 38 employeers. The rest of the authors declare that they have no relevant conflicts of interest 39 Acknowledgement–We thank the two clinical research associate, Gaelle Cavillon and Salima 40 Merazga for their excellent work. We thank Fabien Subtil for his helpful advice for statistical analysis. 41 We also thank the LIFE (Lyon Immunopathology FEderation) community for fruitful discussion. 42© 2020 published by Elsevier. This manuscript is made available under the Elsevier user license https://www. elsevier. com/open-access/userlicense/1.0/